Consider joining our cohort at Nationwide Children's Hospital. Patients will be seen at their Leukodystrophy clinic, where their samples will be collected to build a firmer base of research upon. This also will help them identify potential candidates for clinical trials that may take place as a result in the future. There are currently no clinical trials taking place or slated to take place. Please do not contact the hospital asking to register for a trial. 

While the first model is already being funded, future phases are astronomically expensive. The estimated cost of research and development to clinicals is $2m. Our families cannot cover that cost. Grant funding will be instrumental in being able to pay for this work. Any research toward potentially applicable grants is extremely helpful.

Please consider making a tax-deductible donation to Bradbury Lab to help cover the costs of AAV gene therapy development. TBCD is a disease with a very small patient population, which means we desperately need outside help to be able to achieve our funding goals.